Movatterモバイル変換

[0]ホーム
URL:

MY127600A - Solid oral dosage forms of valsartan - Google Patents

Solid oral dosage forms of valsartan

Info

Publication number
MY127600A
MY127600AMYPI0401893AMY127600AMY 127600 AMY127600 AMY 127600AMY PI0401893 AMYPI0401893 AMY PI0401893AMY 127600 AMY127600 AMY 127600A
Authority
MY
Malaysia
Prior art keywords
dosage forms
oral dosage
solid oral
valsartan
concerned
Prior art date
Application number
Inventor
Robert Frank Wagner
Yoshimitsu Katakuse
Takashi Taike
Fujiki Yamato
Manfred Dr Kohlmeyer
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AgfiledCriticalNovartis Ag
Priority to MYPI0401893priorityCriticalpatent/MY127600A/en
Publication of MY127600ApublicationCriticalpatent/MY127600A/en

Links

Landscapes

Abstract

THE PRESENT INVENTION IS CONCERNED WITH SOLID ORAL DOSAGE FORMS OF COMPRISING (A) AN ACTIVE AGENT SELECTED FROM VALSARTAN AND OPTIONALLY HCTZ, AND (B) PHARMACEUTICALLY ACCEPTABLE ADDITIVES SUITABLE FOR THE PREPARATION OF SOLID ORAL DOSAGE FORMS BY COMPRESSION METHODS.
MYPI04018931997-06-141997-06-14Solid oral dosage forms of valsartanMY127600A (en)

Priority Applications (1)

Application NumberPriority DateFiling DateTitle
MYPI0401893MY127600A (en)1997-06-141997-06-14Solid oral dosage forms of valsartan

Applications Claiming Priority (1)

Application NumberPriority DateFiling DateTitle
MYPI0401893MY127600A (en)1997-06-141997-06-14Solid oral dosage forms of valsartan

Publications (1)

Publication NumberPublication Date
MY127600Atrue MY127600A (en)2006-12-29

Family

ID=47264663

Family Applications (1)

Application NumberTitlePriority DateFiling Date
MYPI0401893MY127600A (en)1997-06-141997-06-14Solid oral dosage forms of valsartan

Country Status (1)

CountryLink
MY (1)MY127600A (en)

Similar Documents

PublicationPublication DateTitle
MY123149A (en)Solid oral dosage forms of valsartan
YU39400A (en)Opioid agonist/antagonist combinations
PT893992E (en) FORMS OF FAST DISINTEGRATION ORAL DOSAGE
IL160222A0 (en)Opioid agonist formulations with releasable and sequestered antagonist
BE2011C028I2 (en)Macrocyclic analogs and methods of their use and preparation
NZ514574A (en)Novel method of treatment
WO1995031985A3 (en)Pharmaceutical compositions comprising an opiate antagonist and calcium salts, their use for the treatment of endorphin-mediated pathologies
RU2008143545A (en) APPLICATION OF AT-1 RECEPTOR ANTAGONIST OR AT-2 RECEPTOR MODULATOR FOR TREATMENT OF DISEASES ASSOCIATED WITH INCREASING THE CONTENT OF AT-1 OR AT-2 RECEPTORS
MX9602683A (en)6-dimethylaminomethyl-1-phenyl-cyclohexane compounds as pharmaceutically active substances.
EP0983767A4 (en)Preventives or remedies for sensitized t cell-related diseases containing il-6 antagonists as the active ingredient
CA2427815A1 (en)Controlled release hydrocodone formulations
IL133397A0 (en)Pharmaceutical compositions for oral administration, comprising an active substance and a cyclodextrin
IL146818A0 (en)New formulation
NZ506188A (en)A pharmaceutical preparation comprising an angiotensin II type 2 receptor agonist, and use thereof
SG188700A1 (en)Use of at-1 receptor antagonist or at-2 receptor modulator for treating diseases associated with an increase of at-1 or at-2 receptors
MY118569A (en)Oral medicinal preparations with reproducible release of the active ingredient gatifloxacin or its pharmaceutically suitable salts or hydrates
TW324662B (en)Benzamide-containing pharmaceutical composition
WO2002015933A3 (en)Combination comprising an at1-receptor antagonist and an insulin secretion enhancer or an insulin sensitiser
AU674379B2 (en)Antitussive
MX9709453A (en)Oral pharmaceutical composition of piperidinoalkanol compounds in solution form.
MY127600A (en)Solid oral dosage forms of valsartan
ECSP972162A (en) SOLID ORAL DOSAGE FORMS CONTAINING VALSARTAN
AU2502301A (en)Medicament and combination of compatible medicaments
MX9606041A (en)Fast dissolving dosage forms.
[8]ページ先頭
©2009-2025 Movatter.jp